Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nano-curcumin in diabetic peripheral neuropathy
IRCT20210925052566N2Phase 3Completed
- Sponsor
- NIMAD
- Start
- May 2022
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3 trial of nanocurcumin in diabetic polyneuropathy (DPN) and type 2 diabetes mellitus (T2DM), sponsored by NIMAD. Started May 2022; status: completed.
02
Drugs
nanocurcumin
03
Conditions
diabetic polyneuropathy (DPN)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT20210925052566N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210925052566N2.